These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8865917)

  • 1. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
    Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
    Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
    Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
    Tanaka S
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) levels and clinical correlations in CAPD patients.
    Lye WC; Hughes K; Leong SO; Lee EJ
    Adv Perit Dial; 1995; 11():131-3. PubMed ID: 8534686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
    Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
    Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
    Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
    Clin Nephrol; 1992 Nov; 38(5):271-6. PubMed ID: 1451340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein Lp(a) in patients with chronic renal insufficiency on hemodialysis].
    Cuxart M; Sans R; Vicente M; Pérez Gallofré A; Masdeu Jufré S; Ponsatí C
    Med Clin (Barc); 1989 May; 92(20):769-71. PubMed ID: 2529402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mortality risk by choice of CAPD versus hemodialysis among elderly patients.
    Lunde NM; Port FK; Wolfe RA; Guire KE
    Adv Perit Dial; 1991; 7():68-72. PubMed ID: 1680460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.